Application

KITE

Kite Pharma, Inc.

Trademark/Service Mark Application, Principal Register

PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Application, Principal Register

Serial Number: 98034369
Filing Date: 06/08/2023

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 98034369
MARK INFORMATION
*MARK KITE
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT KITE
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Kite Pharma, Inc.
*MAILING ADDRESS 2400 Broadway
*CITY Santa Monica
*STATE
(Required for U.S. applicants)
California
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
90404
*EMAIL ADDRESS XXXX
WEBSITE ADDRESS www.kitepharma.com
LEGAL ENTITY INFORMATION
TYPE corporation
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 005 
*IDENTIFICATION pharmaceutical preparations for use in the treatment of cancer and hematological diseases and disorders; biological preparations for use in the treatment of cancer and hematological diseases and disorders; pharmaceutical and biological preparations for immunotherapy, including cell therapy
FILING BASIS SECTION 1(a)
       FIRST USE ANYWHERE DATE At least as early as 08/22/2022
       FIRST USE IN COMMERCE DATE At least as early as 08/22/2022
       SPECIMEN FILE NAME(S)
       ORIGINAL PDF FILE SPE0-242067344-2023060817 5209035499_._KITE.pdf
       CONVERTED PDF FILE(S)
       (1 page)
\\TICRS\EXPORT18\IMAGEOUT 18\980\343\98034369\xml1\ APP0003.JPG
       SPECIMEN DESCRIPTION photograph of Applicant's product label
        WEBPAGE URL None Provided
        WEBPAGE DATE OF ACCESS None Provided
ADDITIONAL STATEMENTS SECTION
ACTIVE PRIOR REGISTRATION(S) The applicant claims ownership of active prior U.S. Registration Number(s) 7048992.
ATTORNEY INFORMATION
NAME Cynthia Smuzynska
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME Gilead Sciences, Inc.
STREET 333 Lakeside Drive
CITY Foster City
STATE California
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP/POSTAL CODE 94404
EMAIL ADDRESS trademarks@gilead.com
OTHER APPOINTED ATTORNEY Gretchen R. Stroud, Jack Wessel, Shelley Lai
CORRESPONDENCE INFORMATION
NAME Cynthia Smuzynska
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE trademarks@gilead.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) tmteam@gilead.com
FEE INFORMATION
APPLICATION FILING OPTION TEAS Standard
NUMBER OF CLASSES 1
APPLICATION FOR REGISTRATION PER CLASS 350
*TOTAL FEES DUE 350
*TOTAL FEES PAID 350
SIGNATURE INFORMATION
SIGNATURE /cynthia smuzynska/
SIGNATORY'S NAME Cynthia Smuzynska
SIGNATORY'S POSITION Sr. Counsel II, IP
SIGNATORY'S PHONE NUMBER 650-552-5563
DATE SIGNED 06/08/2023
SIGNATURE METHOD Sent to third party for signature



PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


Trademark/Service Mark Application, Principal Register

Serial Number: 98034369
Filing Date: 06/08/2023

To the Commissioner for Trademarks:

MARK: KITE (Standard Characters, see mark)
The literal element of the mark consists of KITE. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Kite Pharma, Inc., a corporation of Delaware, having an address of
      2400 Broadway
      Santa Monica, California 90404
      United States
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 005:  pharmaceutical preparations for use in the treatment of cancer and hematological diseases and disorders; biological preparations for use in the treatment of cancer and hematological diseases and disorders; pharmaceutical and biological preparations for immunotherapy, including cell therapy

In International Class 005, the mark was first used by the applicant or the applicant's related company or licensee or predecessor in interest at least as early as 08/22/2022, and first used in commerce at least as early as 08/22/2022, and is now in use in such commerce. The applicant is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any item in the class of listed goods/services, consisting of a(n) photograph of Applicant's product label.

Original PDF file:
SPE0-242067344-2023060817 5209035499_._KITE.pdf
Converted PDF file(s) (1 page)
Specimen File1
Webpage URL: None Provided
Webpage Date of Access: None Provided


Claim of Active Prior Registration(s)
The applicant claims ownership of active prior U.S. Registration Number(s) 7048992.


For informational purposes only, applicant's website address is: www.kitepharma.com

The owner's/holder's proposed attorney information: Cynthia Smuzynska. Other appointed attorneys are Gretchen R. Stroud, Jack Wessel, Shelley Lai. Cynthia Smuzynska of Gilead Sciences, Inc., is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      333 Lakeside Drive
      Foster City, California 94404
      United States
      trademarks@gilead.com

Cynthia Smuzynska submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.

The applicant's current Correspondence Information:
      Cynthia Smuzynska
       PRIMARY EMAIL FOR CORRESPONDENCE: trademarks@gilead.com
       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): tmteam@gilead.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $350 has been submitted with the application, representing payment for 1 class(es).

Declaration

Declaration Signature

Signature: /cynthia smuzynska/   Date: 06/08/2023
Signatory's Name: Cynthia Smuzynska
Signatory's Position: Sr. Counsel II, IP
Signatory's Phone Number: 650-552-5563
Signature method: Sent to third party for signature
Payment Sale Number: 98034369
Payment Accounting Date: 06/08/2023

Serial Number: 98034369
Internet Transmission Date: Thu Jun 08 19:06:45 ET 2023
TEAS Stamp: USPTO/BAS-XX.XXX.XX.XX-20230608190645822
361-98034369-860c79f201a12e4b1f844ebfd9a
c838b5c2da233d45290bc258a109eaef374195a-
DA-06456673-20230608175209035499

Application [image/jpeg]

Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed